Article
Development and clinical validation of a novel 9-gene prognostic model based on multi-omics in pancreatic adenocarcinoma.
Pharmacological research - 1 Feb 2021
Xu Dafeng, Wang Yu, Liu Xiangmei, Zhou Kailun, Wu Jincai, Chen Jiacheng, Chen Cheng, Chen Liang, Zheng Jinfang
Abstract excerpt
The prognoses of patients with pancreatic adenocarcinoma (PAAD) remain poor due to the lack of biomarkers for early diagnosis and effective prognosis prediction. RNA sequencing, single nucleotide polymorphism, and copy number variation data were downloaded from The Cancer Genome Atlas (TCGA). Univariate Cox regression was used to identify prognosis-related genes. GISTIC 2.0 was used to identify significantly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
